Becton, Dickinson and Company (BDX)
Chart Events
Performance Outlook
| Previous Close | 259.00 |
| Open | 259.68 |
| Bid | 256.49 x 800 |
| Ask | 258.85 x 1300 |
| Day's Range | 256.09 - 260.34 |
| 52 Week Range | 224.71 - 267.37 |
| Volume | 1,593,279 |
| Avg. Volume | 1,304,536 |
| Market Cap | 74.682B |
| Beta (5Y Monthly) | 0.77 |
| PE Ratio (TTM) | 45.76 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 3.32 (1.27%) |
| Ex-Dividend Date | Sep 08, 2021 |
| 1y Target Est | N/A |
- PR Newswire
BD Joins the Race to Zero: Largest Alliance Dedicated to Achieving Net Zero Emissions by 2050
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, with support from a number of partners including Global Citizen, is proud to announce the company has officially signed on to the Race to Zero via the most ambitious Science Based Targets initiative (SBTi), the Business Ambition for 1.5⁰C, and this milestone will be celebrated on September 25, 2021 at Global Citizen LIVE.
- PR Newswire
BD Partners with Washington State in Back-to-School Testing Effort
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been selected by the state of Washington as a digitally read, rapid antigen test option for COVID-19 testing and screening in K-12 schools across the state.
- PR Newswire
BD to Present at Two Upcoming Virtual Healthcare Investor Conferences in September
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will present at the following upcoming virtual investor conferences:
